What will be the key issues shaping bio/pharma supply chains in 2025? The latest episode of DCAT Value Chain Insights’ original podcast Production to Prescription, examines the latest hot-button issues: 

• The impact of potential changes in US tariff and trade policy;  

• The outlook for product-specific supply chains for sterile injectables and antibody drug conjugates; and  

• The latest on how companies are advancing upstream supplier risk monitoring and predictive risk planning, including through digitalization and artificial intelligence.  

This episode features perspectives from Derron Stark, EY-Parthenon Partner, Strategy & Transactions – Health Sciences & Wellness, Supply Chain, Ernst & Young LLP. Click here to listen.  

DCAT Value Chain Insights’ Production to Prescription podcast features thought leaders with expert views on the major happenings impacting the global bio/pharmaceutical manufacturing value chain and industry performance. 

Click here for the latest episode and here for the full 2025 schedule.